TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer May 30, 2014
TCL Archive Proof of principle needed before launching “big science” program, advisors say. March 11, 2005
TCL Archive In Brief: CDP Awarded Contract To Do Facilities Survey; MIHICH Appointment Official; Kraybill Retires August 24, 1984
TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL July 11, 2014
